222 related articles for article (PubMed ID: 29763992)
1. Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: An application to antiepileptic drug use in 4.9 million pregnant women in France.
Blotière PO; Weill A; Dalichampt M; Billionnet C; Mezzarobba M; Raguideau F; Dray-Spira R; Zureik M; Coste J; Alla F
Pharmacoepidemiol Drug Saf; 2018 Jul; 27(7):763-770. PubMed ID: 29763992
[TBL] [Abstract][Full Text] [Related]
2. Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health.
Mostacci B; Bisulli F; Poluzzi E; Cocchi G; Piccinni C; Curti A; Simonazzi G; Astolfi G; Rizzo N; Zenesini C; D'Alessandro R; Tinuper P;
J Neurol Neurosurg Psychiatry; 2018 Sep; 89(9):983-988. PubMed ID: 29549194
[TBL] [Abstract][Full Text] [Related]
3. Use of antiepileptic drugs during pregnancy and risk of spontaneous abortion and stillbirth: population based cohort study.
Bech BH; Kjaersgaard MI; Pedersen HS; Howards PP; Sørensen MJ; Olsen J; Parner ET; Pedersen LH; Vestergaard M; Christensen J
BMJ; 2014 Aug; 349():g5159. PubMed ID: 25150301
[TBL] [Abstract][Full Text] [Related]
4. Antiepileptic drug exposure in pregnancy and pregnancy outcome from national drug usage data.
Richards N; Reith D; Stitely M; Smith A
BMC Pregnancy Childbirth; 2018 Apr; 18(1):84. PubMed ID: 29625554
[TBL] [Abstract][Full Text] [Related]
5. Development of a mother-child database for drug exposure and adverse event detection in the Military Health System.
Taylor LG; Thelus Jean R; Gordon G; Fram D; Coster T
Pharmacoepidemiol Drug Saf; 2015 May; 24(5):510-7. PubMed ID: 25833769
[TBL] [Abstract][Full Text] [Related]
6. The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months.
Vajda FJ; O'Brien TJ; Hitchcock A; Graham J; Lander C
J Clin Neurosci; 2003 Sep; 10(5):543-9. PubMed ID: 12948456
[TBL] [Abstract][Full Text] [Related]
7. Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillance.
MacDonald SC; Cohen JM; Panchaud A; McElrath TF; Huybrechts KF; Hernández-Díaz S
Pharmacoepidemiol Drug Saf; 2019 Sep; 28(9):1211-1221. PubMed ID: 31328328
[TBL] [Abstract][Full Text] [Related]
8. Inferring pregnancy episodes and outcomes within a network of observational databases.
Matcho A; Ryan P; Fife D; Gifkins D; Knoll C; Friedman A
PLoS One; 2018; 13(2):e0192033. PubMed ID: 29389968
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of pregnancy outcome records in the German Pharmacoepidemiological Research Database (GePaRD).
Mikolajczyk RT; Kraut AA; Garbe E
Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):873-80. PubMed ID: 23733705
[TBL] [Abstract][Full Text] [Related]
10. Antiepileptic drugs, foetal malformations and spontaneous abortions.
Vajda FJ; O'Brien TJ; Graham JE; Hitchcock AA; Lander CM; Eadie MJ
Acta Neurol Scand; 2017 Mar; 135(3):360-365. PubMed ID: 27573510
[TBL] [Abstract][Full Text] [Related]
11. Congenital malformations in infants exposed to antiepileptic medications in utero at Boston Medical Center from 2003 to 2010.
Deck GM; Nadkarni N; Montouris GD; Lovett A
Epilepsy Behav; 2015 Oct; 51():166-9. PubMed ID: 26283306
[TBL] [Abstract][Full Text] [Related]
12. Termination of pregnancy in women with epilepsy - A retrospective single center study.
Goldstein L; Shihman B; Amiel N; Benninger F
Epilepsy Behav; 2018 Oct; 87():89-91. PubMed ID: 30131224
[TBL] [Abstract][Full Text] [Related]
13. Optimizing an algorithm for the identification and classification of pregnancy outcomes in German claims data.
Wentzell N; Schink T; Haug U; Ulrich S; Niemeyer M; Mikolajczyk R
Pharmacoepidemiol Drug Saf; 2018 Sep; 27(9):1005-1010. PubMed ID: 30022557
[TBL] [Abstract][Full Text] [Related]
14. Examination of the prescription of antiepileptic drugs to prenatal and postpartum women in Japan from a health administrative database.
Ishikawa T; Obara T; Jin K; Nishigori H; Miyakoda K; Suzuka M; Ikeda-Sakai Y; Akazawa M; Nakasato N; Yaegashi N; Kuriyama S; Mano N
Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):804-811. PubMed ID: 30854762
[TBL] [Abstract][Full Text] [Related]
15. Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink.
Naleway AL; Gold R; Kurosky S; Riedlinger K; Henninger ML; Nordin JD; Kharbanda EO; Irving S; Cheetham TC; McCarthy NL
Vaccine; 2013 Jun; 31(27):2898-903. PubMed ID: 23639917
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy, delivery, and outcome for the child in maternal epilepsy.
Veiby G; Daltveit AK; Engelsen BA; Gilhus NE
Epilepsia; 2009 Sep; 50(9):2130-9. PubMed ID: 19490036
[TBL] [Abstract][Full Text] [Related]
17. Antiepileptic drugs and intrauterine death: A prospective observational study from EURAP.
Tomson T; Battino D; Bonizzoni E; Craig JJ; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Neurology; 2015 Aug; 85(7):580-8. PubMed ID: 26187231
[TBL] [Abstract][Full Text] [Related]
18. Epilepsy, pregnancy, and major birth anomalies: an Italian prospective, controlled study.
Tanganelli P; Regesta G
Neurology; 1992 Apr; 42(4 Suppl 5):89-93. PubMed ID: 1574184
[TBL] [Abstract][Full Text] [Related]
19. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India.
Thomas SV; Jose M; Divakaran S; Sankara Sarma P
Epilepsia; 2017 Feb; 58(2):274-281. PubMed ID: 28084641
[TBL] [Abstract][Full Text] [Related]
20. The French Pregnancy Cohort: Medication use during pregnancy in the French population.
Bérard A; Abbas-Chorfa F; Kassai B; Vial T; Nguyen KA; Sheehy O; Schott AM
PLoS One; 2019; 14(7):e0219095. PubMed ID: 31314794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
